Evaluating The Safety Profile Of Nintedanib Among ILD Patients In A Tertiary Care Hospital: A Prospective Research Approach Focusing On Adverse Drug Reactions. Int. J. Environ. Sci. [Internet]. 2025 Oct. 8 [cited 2025 Dec. 7];:5496-502. Available from: https://theaspd.com/index.php/ijes/article/view/11161